- Document1422273_81098048EN_Leaflet_Karl-Fischer-Elektroden.pdfuploaded byjhuampe
- DocumentTasks of the Product Team on the Handling of the Initial Marketing Authorisation Applicationuploaded byjhuampe
- DocumentDraft Guideline on the Acceptability of Names for Human Productsuploaded byjhuampe
- DocumentGuideline on the Acceptability of Names for Human Medicinal Products Processed Through the Centralised Procedureuploaded byjhuampe
- DocumentNRG Position Paper Re-use of Invented Names of Medicinaluploaded byjhuampe
- DocumentNRG Position Paper Re-use of Invented Names of Medicinal Productsuploaded byjhuampe
- DocumentScientific Aspects and Working Definitions Foruploaded byjhuampe
- DocumentCompassionate Use for Centralised Medicinal Productsuploaded byjhuampe
- DocumentOverview of Comments Received Onuploaded byjhuampe
- DocumentCommittee for Medicinal Products for Human Useuploaded byjhuampe
- DocumentProcedural Advice on CHMP_CAT Rapporteur_co-rapporteuruploaded byjhuampe
- Document28_anexo-15uploaded byjhuampe
- Document24_anexo-11buploaded byjhuampe
- Document01_prologouploaded byjhuampe
- Document06_capitulo-3uploaded byjhuampe
- DocumentDirectiva 2001_83_CE 06 Noviembreuploaded byjhuampe
- DocumentTLS2200_UG_v4.04_ES[1]uploaded byjhuampe
- DocumentElectrodes_for_Titration.pdfuploaded byjhuampe
- DocumentInstrumentuploaded byjhuampe
- DocumentWorking Procedures of the Pharmacopeial Discussion Group (PDG)uploaded byjhuampe